Tawnia Palmer Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1294 Chestnut St, Clarkston, WA 99403 Phone: 509-769-6224 |
Dr. Dana Majors Wiggins Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2452 17th St, Clarkston, WA 99403 Phone: 208-305-2910 |
Breeana Ragains Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1253 Poplar St, Clarkston, WA 99403 Phone: 509-769-6326 |
Erin Parry Henson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2261 Deer Pointe Dr, Clarkston, WA 99403 Phone: 435-669-6529 |
Mrs. Terri L Gregg, SLP, MS/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1432 Highland Ave, Highland Elementary, Clarkston, WA 99403 Phone: 509-758-5531 |
Keri Dee Fleming, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1144 16th Ave, Clarkston, WA 99403 Phone: 509-552-9718 |
Mrs. Sarah Marie Power, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1253 Poplar St, Clarkston, WA 99403 Phone: 509-758-2503 |
Merrie Louise Fleming, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2403 Linda Ln, Clarkston, WA 99403 Phone: 509-254-1808 |
News Archive
Most wives would say their husbands are notoriously bad about avoiding the doctor's office. Erectile dysfunction (ED) might be the only problem that prompts some men to go to a physician. According to a new study, it could be their best chance at finding out they have underlying cardiovascular disease.
The World Health Organization (WHO) has urged countries to put in place preventive measures and enhance preparedness ready for the possible re-emergence of SARS (severe acute respiratory syndrome) and avian influenza A (H5N1) in humans.
Almost half of the patients who die in intensive care units die within 24 hours, but the environment is not equipped to provide good end-of-life care. Most relatives are nevertheless happy with the care given, shows a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the issuance of patents covering its novel Toll-like Receptor (TLR) - targeted compounds. The Company's TLR-targeted compounds are based on synthetic DNA and RNA, which it refers to as immune modulatory oligonucleotides, or IMO®.
› Verified 4 days ago